D-0773-2016 Class III Terminated

Recalled by Teva Pharmaceuticals USA — North Wales, PA

FDA drug recall D-0773-2016 was initiated by Teva Pharmaceuticals USA on Nov 19, 2015 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles. The recall status is terminated (terminated Nov 15, 2016). Affected quantity: 576 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 23, 2016
Initiation Date
Nov 19, 2015
Termination Date
Nov 15, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
576 bottles

Product description

NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL

Reason for recall

Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.

Distribution pattern

Nationwide and Puerto Rico.

Code information

Lot #: 05N533, Exp 11/16

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0773-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0773-2016. Report a data issue: hello@regdatalab.com.